Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
02/2010
02/10/2010CN100588401C Method for preparing sulfonamide compound liposome and its formulation
02/10/2010CN100588397C Armillarisin A solution preparation and its preparing method
02/09/2010US7659404 Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
02/09/2010US7659385 Polynucleotides encoding molecules designated LDCAM
02/09/2010US7659293 α-Amino-N-hydroxy-acetamide derivatives
02/09/2010US7659267 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding
02/09/2010US7659263 (E)-3-[4-({1-[(11-cyclohexyl-8-methoxy-4,5-dihydro-6-oxa-1-thia-3b-azabenzo[e]cyclopenta[a]azulene-2-carbonyl)amino]cyclobutanecarbonyl}amino)phenyl]acrylic acid; RNA-dependent RNA polymerase inhibitory activity; hepatitis C
02/09/2010US7659117 Immunostimulatory fusion proteins comprising polypeptide antigen for generating protective DC-induced T-cell-mediated immune responses; metastatic cancers
02/09/2010US7659114 Recombinant feline herpesvirus type 1 and polyvalent vaccine using the same
02/09/2010US7658934 Chlamydia antigens and protein vaccine
02/09/2010US7658929 Derived from pathogenic microorganisms, useful for vaccination and diagnosis; tuberculosis; detection of CD4+ T lymphocytes recognizing at least one glycopeptide obtained from pathogenic microorganism
02/09/2010CA2466720C Medicament for the treatment of viral skin and tumour diseases
02/09/2010CA2439593C Heterocyclic compounds for aging-related and diabetic vascular complications
02/09/2010CA2430827C Coniosetin and derivatives thereof, process for the preparation and the use thereof
02/09/2010CA2422496C Disinfectant comprising an amine and an alkanolamine
02/09/2010CA2418224C Pharmaceutical composition
02/09/2010CA2413061C Serine protease inhibitors
02/09/2010CA2375201C Crystal of (r)-lansoprazole
02/09/2010CA2294274C Compositions and methods for reversibly increasing permeability of biomembranes
02/09/2010CA2287469C Interactive system for presenting and eliminating substances
02/09/2010CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
02/08/2010CA2672181A1 Adhesive patch for protecting and treating viral cutaneous lesions
02/04/2010WO2010014943A2 Methionine analogs and methods of using same
02/04/2010WO2010014888A2 Methods of enhancing opsonophagocytosis in response to a pathogen
02/04/2010WO2010014739A2 Heterocyclic modulators of tgr5
02/04/2010WO2010014676A1 Composition and method for treatment of mrsa
02/04/2010WO2010014304A1 Compositions and methods related to staphylococcal bacterium proteins
02/04/2010WO2010014248A2 Antiviral activity of the protein scytovirin and methods of use
02/04/2010WO2010014134A1 Compounds and pharmaceutical compositions for the treatment of viral infections
02/04/2010WO2010013640A1 Potentiator of therapeutic efficacy on infectious disease
02/04/2010WO2010013601A1 Microneedle device and method for increasing the response of japanese encephalitis virus antigen with the microneedle device
02/04/2010WO2010013466A1 Inhibition of replication of hepatitis c virus by cdk inhibitor
02/04/2010WO2010013350A1 S/o type transdermal immunizing agent
02/04/2010WO2010013222A1 Pyrrole carboxylic acid derivatives as antibacterial agents
02/04/2010WO2010012852A1 Use of bacteria of the genus tenacibaculum for quorum quenching
02/04/2010WO2010012840A1 Use of nucleoside analogs as anti-koi herpes virus molecules
02/04/2010WO2010012466A1 Antitumor properties of no modified protease inhibitors
02/04/2010WO2010012438A2 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor
02/04/2010WO2010012381A1 Streptospirole derivatives
02/04/2010WO2010012244A1 Small rna interference target site sequences of hepatitis b virus and small interference rnas and the compositions and uses thereof
02/04/2010WO2010012138A1 7-[4-(aminomethyl)-4-fluoro-3-(alkoxyimino)pyrrolidin-1-yl] quinoline carboxylic acid derivatives and methods for preparation
02/04/2010WO2010012131A1 The usage of medicinal composition containing oil of zedoary turmeric in manufacture of medicaments
02/04/2010WO2010012069A1 Multivalent vaccines based on papaya mosaic virus and uses thereof
02/04/2010WO2010012045A1 Influenza vaccines
02/04/2010WO2009151496A9 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells
02/04/2010WO2009146807A8 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes
02/04/2010WO2009137611A9 Treatment of pulmonary fungal infection with voriconazole via inhalation
02/04/2010WO2009129525A3 Antifungal and anti-cariogenic cellobio-oligosaccharides produced by dextransucrase
02/04/2010WO2009099596A4 Macrocyclic serine protease inhibitors
02/04/2010US20100029780 Topical composition
02/04/2010US20100029747 Methods and compositions for inhibiting the function of polynucleotide sequences
02/04/2010US20100029715 Polymorphic forms of a macrocyclic inhibitor of hcv
02/04/2010US20100029686 Hcv protease inhibitors and uses thereof
02/04/2010US20100029679 Antibacterial quinoline derivatives
02/04/2010US20100029675 Pyrimidine-2, 4-diamine JAK2 Kinase inhibiting anti-inflammation use
02/04/2010US20100029669 3-(substituted ethyl)-rifamycin derivatives useful as antimicrobial agents
02/04/2010US20100029666 Macrocyclic Quinoxaline Compounds as HCV NS3 Protease Inhibitors
02/04/2010US20100029655 Processes For The Preparation Of Anti-Viral Compounds And Compositions Containing Them
02/04/2010US20100029635 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents
02/04/2010US20100029634 Chemokine Receptor Modulators
02/04/2010US20100029632 improved pharmacokinetics
02/04/2010US20100029623 4-(1-amino-ethyl)-cyclohexylamine derivatives
02/04/2010US20100029604 Antibacterial combination and its use
02/04/2010US20100029600 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
02/04/2010US20100029597 Reca inhibitors with antibiotic activity, compositions and methods of use
02/04/2010US20100029591 Combinations of a pyrimidine containing nnrti with rt inhibitors
02/04/2010US20100029579 Antiviral compounds
02/04/2010US20100029568 Tighter-binding c-peptide inhibitors of hiv-1 entry
02/04/2010US20100029565 RECOMBINANT B. pseudomallei ADHESIN PROTEIN AND METHODS AND USES THEREOF
02/04/2010US20100029557 Alpha-lactalbumin composition
02/04/2010US20100029484 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
02/04/2010US20100028970 Medium for the Production of Tiacumicin B
02/04/2010US20100028905 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
02/04/2010US20100028470 Isolated extract of walnuts, method for its obtention and its use
02/04/2010US20100028458 Mild composition for skin disinfection
02/04/2010US20100028456 Broad-spectrum antiviral composition with excellent preservation stabilty
02/04/2010US20100028415 Method of Inducing Neutralizing Antibodies to Human Immunodeficiency Virus
02/04/2010US20100028383 Chemically defined stabiliser
02/04/2010US20100028382 Lentival Vector-Based Vaccine
02/04/2010US20100028381 Formulation for delivery of immune response modifiers
02/04/2010US20100028379 Methods of vaccine administration
02/04/2010US20100028346 Novel synergistic effects
02/04/2010US20100028334 Compositions and methods to potentiate colistin activity
02/04/2010US20100028313 Compositions and methods for treatment of skin disorders
02/04/2010US20100028300 Macrocyclic peptides active against the hepatitis c virus
02/04/2010US20100028299 Methods and compositions of treating a flaviviridae family viral infection
02/04/2010US20100028298 Interferon type i supporting compounds
02/04/2010CA2742288A1 Multivalent vaccines based on papaya mosaic virus and uses thereof
02/04/2010CA2733390A1 Methionine analogs and methods of using same
02/04/2010CA2733356A1 Influenza vaccines
02/04/2010CA2732618A1 Pyrrole carboxylic acid derivatives as antibacterial agents
02/04/2010CA2732437A1 Toll-like receptor agonist formulations and their use
02/04/2010CA2732307A1 Composition and method for treatment of mrsa
02/04/2010CA2730659A1 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor
02/04/2010CA2730489A1 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
02/03/2010EP2149604A1 Collections of repeat proteins comprising repeat modules
02/03/2010EP2149571A1 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
02/03/2010EP2149557A1 Styrylquinolines, their process of preparation and their therapeutic uses
02/03/2010EP2149374A1 Pharmaceutical composition comprising the combinaton of the anti-microbial agent ciprofloxacin and the antioxidant agent ascorbic acid for the treatment of urinary infections
02/03/2010EP2148884A1 Antibacterial 1,4,5-substituted aminoglycoside analogs
1 ... 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 ... 1798